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Background:  The anti-CTLA4 antibody, ipilumumab (ipi), 
improves survival in metastatic melanoma. With increased 
survival and improved extracranial control, a greater 
proportion of melanoma patients develop brain metastases. 
The effects of combining radiotherapy (RT), whole brain RT 
(WBRT) or stereotactic radiosurgery (SRS) with Ipi are 
unclear.  This study reports the incidence and factors 
associated with acute radiation effect (ARE), in patients with 
melanoma brain metastases treated with ipi and brain RT.  
Methods:  All patients with melanoma brain metastases who 
received WBRT or SRS and ipi at our institution from 2008-
2014 were included. Outcome measures included incidence 
of ARE, treatment response, progression free survival (PFS) 
and overall survival (OS). Variables included baseline patient 
characteristics, type of RT (WBRT or SRS), dosimetric 
parameters (including V12 Gy for SRS), time between RT and 
ipi treatment. Using our prospective brain metastases 
database, incidence of ARE was compared against patients 
treated with SRS alone at our institution. 
Results:   A total of 688 patients in our database received SRS 
upfront and 54 pts met eligibility for evaluation of RT and ipi 
of which 34 were evaluable (20 were excluded due to lack of 
follow up imaging). With a median follow up of 7.4 months, 
OS was 6.4 months and PFS was 2.7 months. In patients 
treated with WBRT alone, no ARE was seen. In those who 
received SRS with ipi, 11/27 (41%) patients developed ARE. 
Of these, 7 patients had received RT within 4 months of ipi 
(SRS = 4, SRS+WBRT = 3) and 4 received RT outside of this 
window (SRS = 2, SRS+WBRT= 2). Out of the 688 patients 
treated with upfront SRS, 11% developed ARE.  Larger tumor 
volume and higher V12Gy were associated with a higher rate 
of ARE. A total of 6 patients received steroids for 
symptomatic ARE of which only 1 patient did not respond and 
required surgical intervention. The pathology showed treated 
melanoma along with necrosis, and predominantly 
inflammatory T cells and macrophages.  
Conclusions:  The incidence of ARE was greater in patients 
treated with SRS and ipi (41%) compared to SRS alone (10%). 
In contrast, no ARE was seen after WBRT and ipi. In the 
majority of cases, symptomatic ARE responded to steroids. In 
1 case requiring surgery, pathology demonstrated an 
increased immunological effect.  
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Radiotherapy with external photon or electron beams 
represents one of the most widespread methods in the 
treatment of cancer disease. Recently the irradiation 
techniques have reached an accuracy of few mm. Intensity-
Modulated-Radiation-Therapy (IMRT) is one of the most 
advanced irradiation techniques with external X-ray beams. 
It allows to conform in more detail the beam to the tumor 
volume adjusting a set of programmable multi-leaf collimator 
which can assume very different shapes. Then a very 
accurate instrument is required to verify the real released 
doses. Pre-treatment quality assurance play a central role in 
a typically radiotherapy treatment session because 
guarantees the success the treatment.  
Devices devoted to quality assurance are dosimeter with 
different forms and dimensions. An important category is 
represented by 2D devices which are able to provide a 
measure of the dose distribution on a given area. The most 
common are ionization chamber arrays, films and Electronic 
Portal Imaging Devices (EPID). All these devices presents 
some drawbacks which limit their performance like 2D 
dosimeters, especially for IMRT. Ionization chamber arrays 
have a spatial resolution limited to few mm. Film dosimeters, 
on the contrary, can provide an higher spatial resolution with 
the drawback that it must be processed after taking into 
account other parameters which can influence the correct 
dose measure like fading, UV sensitivity, temperature and so 
on. EPID is applied as a 2D dosimeter, but an algorithm 
software is needed to convert the registered signal by an 
EPID into dose values and it is difficult to realize a unique 
software devoted to this aim. 
The present work will demonstrate that detectors based on 
the Gas Electron Multiplier (GEM) technology [1] with a 
medipix C-MOS read-out can be a valid alternative for 2D 
dosimetry respect to the traditional devices. This type of 
detector, called “GEMpix” [2], shows some interesting 
characteristics which can overcome the typical drawbacks 
observed in the traditional 2D dosimeters [3]. In particular 
the GEMpix, working in a bi-GEM configuration, can perform 
2D real time dose distribution measurements with a spatial 
resolution comparable the gafchromic films. A comparison 
between GEMpix and gafchromics has been performed in 
order to test its ability to work as 2D dosimeter. Dose 
matching between the two dosimeters has been evaluated 
applying a the gamma-index test analysis with the commonly 
accepted criteria of distance to agreement < 3 mm  and dose 
difference < 3%. 
 
 
 
The figure shows a particular dose distribution as measured 
by GEMpix and by a gafchromic film. In the third panel a 
gamma index test map shows the areas where gamma index 
is less 1. This is verified in the 90,5 % of points. 
 
Keywords: dosimetry, IMRT, GEM  
 
References: 
[1] F. Sauli, “Nucl. Instr. and Meth.” A 386 (1987) 531. 
[2] F.Murtas, Applications of triple GEM detectors beyond 
particle and nuclear physics, 2014 JINST 9 C01058 
[3] G. Claps, A study of a triple GEM detector as real time 
dosimeter in external photon beam radiotherapy, PhD 
Thesis, University of Tor Vergata, 3 June 2015, Rome 
 
 
 
 
